Fairway Wealth LLC purchased a new stake in Aflac Incorporated (NYSE:AFL – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 950 shares of the financial services provider’s stock, valued at approximately $98,000.
Several other institutional investors and hedge funds also recently made changes to their positions in AFL. Whipplewood Advisors LLC bought a new stake in Aflac in the 4th quarter valued at $26,000. Darwin Wealth Management LLC bought a new stake in shares of Aflac in the third quarter valued at about $34,000. BankPlus Trust Department acquired a new position in shares of Aflac during the fourth quarter worth about $34,000. Raelipskie Partnership bought a new position in shares of Aflac during the third quarter worth about $38,000. Finally, OFI Invest Asset Management acquired a new stake in Aflac in the 4th quarter valued at approximately $38,000. Institutional investors and hedge funds own 67.44% of the company’s stock.
Aflac Price Performance
NYSE:AFL opened at $106.73 on Tuesday. The firm’s fifty day moving average price is $105.15 and its two-hundred day moving average price is $107.73. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The company has a market cap of $58.34 billion, a P/E ratio of 11.12, a P/E/G ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50.
Insiders Place Their Bets
In related news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.90% of the company’s stock.
Analyst Ratings Changes
AFL has been the subject of several research reports. Keefe, Bruyette & Woods decreased their price target on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. Barclays lowered their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Wells Fargo & Company reduced their price objective on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. Morgan Stanley raised their price objective on Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a report on Friday, February 28th. Finally, Evercore ISI dropped their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Aflac currently has a consensus rating of “Hold” and a consensus price target of $103.36.
Check Out Our Latest Report on AFL
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
- Five stocks we like better than Aflac
- Industrial Products Stocks Investing
- How to Protect Your Portfolio When Inflation Is Rising
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- What Does a Stock Split Mean?Â
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.